Sol Gel Technologies Ltd
NASDAQ:SLGL
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Realty Income Corp
NYSE:O
|
Real Estate
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
| US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
0.366
2.22
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
Abbvie Inc
NYSE:ABBV
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Realty Income Corp
NYSE:O
|
US |
|
|
Walt Disney Co
NYSE:DIS
|
US |
|
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
This alert will be permanently deleted.
Sol Gel Technologies Ltd
Sol Gel Technologies Ltd
Total Liabilities
Sol Gel Technologies Ltd
Total Liabilities Peer Comparison
TEVA
RDHL
MDWD
Competitive Total Liabilities Analysis
Latest Figures & CAGR of Competitors
| Company | Total Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Sol Gel Technologies Ltd
NASDAQ:SLGL
|
Total Liabilities
$7.1m
|
CAGR 3-Years
0%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
N/A
|
|
|
Teva Pharmaceutical Industries Ltd
NYSE:TEVA
|
Total Liabilities
$35B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
4%
|
|
|
Redhill Biopharma Ltd
NASDAQ:RDHL
|
Total Liabilities
$22m
|
CAGR 3-Years
-50%
|
CAGR 5-Years
4%
|
CAGR 10-Years
15%
|
|
I
|
InterCure Ltd
NASDAQ:INCR
|
Total Liabilities
₪331.5m
|
CAGR 3-Years
86%
|
CAGR 5-Years
83%
|
CAGR 10-Years
65%
|
|
|
Mediwound Ltd
NASDAQ:MDWD
|
Total Liabilities
$39.4m
|
CAGR 3-Years
18%
|
CAGR 5-Years
4%
|
CAGR 10-Years
4%
|
|
R
|
Rekah Pharmaceutical Industry Ltd
TASE:REKA
|
Total Liabilities
₪326.2m
|
CAGR 3-Years
10%
|
CAGR 5-Years
11%
|
CAGR 10-Years
3%
|
See Also
What is Sol Gel Technologies Ltd's Total Liabilities?
Total Liabilities
7.1m
USD
Based on the financial report for Jun 30, 2024, Sol Gel Technologies Ltd's Total Liabilities amounts to 7.1m USD.
What is Sol Gel Technologies Ltd's Total Liabilities growth rate?
Total Liabilities CAGR 5Y
-4%
Over the last year, the Total Liabilities growth was 4%.
You don't have any saved screeners yet
